Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/m

BRIDGEWATER, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“A

UBS analyst Ashwani Verma maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Buy and raises th

BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“A

On July 6, 2026, Alkermes plc (the "Company") and Amneal Pharmaceuticals LLC ("Amneal&#3

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significan

MILAN and BRIDGEWATER, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Zambon and Amneal Pharmaceuticals tod

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Bioscienc

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b

Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a l

On June 10, 2026, Amneal Pharmaceuticals Inc (AMRX) shares rose 4.4% today, bringing the current pri

Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals PR New

Amneal's Commitment Helps Support a Reliable Supply of Essential Medicines for Uninsured and Underse

Amneal Pharmaceuticals NASDAQ: AMRX Co-Founder, President and Co-Chief Executive Officer Chirag Pate

Amneal Pharmaceuticals, Inc. (AMRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

AMRX is expanding into GLP-1 manufacturing and biosimilars, using partnerships and acquisitions to s

AMRX faces Rytary generic pressure in 2026, but growth in generics, injectables, biosimilars, and hi

AMRX's 2026 outlook is driven by higher profit expectations, a steady launch cadence, and growth fro

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

AMRX gains after FDA approval of ready-to-use romidepsin injection, with 180-day exclusivity and a p

Overall Interim Findings (Entire Study Population, 214Patients; Six-Week Analysis)All 214 patients w

BRIDGEWATER, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“A

Amneal Pharmaceuticals (NASDAQ:AMRX) said on Thursday the US Food and Drug Administration has approv

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ:AMRX) today announc

Barclays analyst Glen Santangelo maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight

Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars pla

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  On Friday, 469 companies hit new 52-week lows.

  On Friday, 497 companies set new 52-week lows.

  On Tuesday, 838 companies hit new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Thursday, 529 companies set new 52-week lows.

  On Tuesday, 250 stocks hit new 52-week lows.

  During Monday's trading, 1214 companies set new 52-week lows.

    On Monday, 721 companies achieved new lows for the year.